Establishment of PDX model of oral cancer and PDX-derived cell lines, and usefulness of anti-HER2 antibody therapy

被引：0
|
作者：
Seki, Yuki [1 ]
Kariya, Ryusho [2 ]
Yoshida, Ryoji [3 ]
Kawahara, Kenta [3 ]
Hirayama, Masatoshi [3 ]
Takahashi, Nozomu [3 ]
Nakamoto, Masafumi [3 ]
Takeshita, Hisashi [3 ]
Okada, Seiji [2 ]
Nakayama, Hideki [3 ]
机构：
[1] Kumamomto Univ, Grad Sch Med Sci, Kumamoto, Japan
[2] Kumamoto Univ, Div Hematopoiesis, Joint Res Ctr Human Retrovirus Infect, Kumamoto, Japan
[3] Kumamoto Univ, Dept Oral & Maxillofac Surg, Fac Life Sci, Kumamoto, Japan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2325
引用
收藏
页码：1074 / 1074
页数：1
相关论文
共 50 条
  • [21] Anti-HER2 monoclonal antibody therapy with adjuvant chemotherapy for breast cancer
    Perez, Edith A.
    ANNALS OF ONCOLOGY, 2006, 17 : 39 - 39
  • [22] Optimisation of protocols for the establishment of pancreatic cancer organoids and cell lines from patient derived xenografts (PDX) tumour models
    Nelson, S.
    Roche, S.
    O'neill, F.
    Larkin, A.
    Crown, J.
    Walsh, N.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E108 - E108
  • [23] Establishment of a patient-derived xenograft(PDX) model of small intestine cancer.
    Matsumoto, Yasunori
    Kano, Masayuki
    Sakata, Haruhito
    Murakami, Kentaro
    Endo, Satoshi
    Toyozumi, Takeshi
    Suito, Hiroshi
    Okada, Koichiro
    Kamata, Toshiki
    Ryuzaki, Takahiro
    Kinoshita, Kazuya
    Hirasawa, Soichiro
    Sasaki, Takuma
    Matsubara, Hisahiro
    CANCER SCIENCE, 2021, 112 : 614 - 614
  • [24] Establishment of a realistic patient derived xenograft (PDX) model for prostate cancer bone metastasis
    Konkol, Yvonne
    Valta, Maija
    Bernoulli, Jenni
    Taimen, Pekka
    Bostrom, Peter
    Harkonen, Pirkko
    Halleen, Jussi
    Tuomela, Johanna M.
    CANCER RESEARCH, 2016, 76
  • [25] The combination of Talazoparib with anti-her2 drugs shows efficacy in drug resistant Her2+and low Her2 PDX models
    Bozek, Kathryn
    Buchanan, Marguerite
    Lan, Cathy
    Lafleur, Josiane
    Darini, Cedric
    Krzemien, Urszula
    Aguilar-Mahecha, Adriana
    Basik, Mark
    CANCER RESEARCH, 2022, 82 (12)
  • [26] Establishment of a panel of prostate patient derived xenograft (PDX) models and evaluation of anti-androgen therapy
    Davis, Jason
    Oakden, Anthony
    Wrigley, Jane
    Roberts, Chira
    Qian, W.
    Fan, Bin
    Collins, A.
    Ouyang, Davy
    Cai, Jie
    Kumari, Rajendra
    Yin, Yinfei
    CANCER RESEARCH, 2019, 79 (13)
  • [27] Characterization of a panel of 79 PDX-derived cell lines with a focus on the EGFR exon 20 insertion mutation-driven NSCLC model LXFE 2478
    Kelter, Gerhard
    Peille, Anne-Lise
    Fehr, Jutta
    Klett, Hagen
    Maier, Armin
    Posch, Markus
    Metz, Thomas M.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [28] Endometrial cancer PDX-derived organoids (PDXOs) and PDXs with FGFR2c isoform expression are sensitive to FGFR inhibition
    Sengal, Asmerom T.
    Bonazzi, Vanessa
    Smith, Deborah
    Moiola, Cristian P.
    Lourie, Rohan
    Rogers, Rebecca
    Colas, Eva
    Gil-Moreno, Antonio
    Frentzas, Sophia
    Chetty, Naven
    Perrin, Lewis
    Pollock, Pamela M.
    NPJ PRECISION ONCOLOGY, 2023, 7 (01)
  • [29] Modelling of pancreatic cancer biology: transcriptomic signature for 3D PDX-derived organoids and primary cell line organoid development
    Nelson, Shannon R.
    Zhang, Chenxi
    Roche, Sandra
    O'Neill, Fiona
    Swan, Niall
    Luo, Yonglun
    Larkin, AnneMarie
    Crown, John
    Walsh, Naomi
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [30] In Vitro Evaluation of the Anti-EGFR Antibody Cetuximab and the Anti-HER2 Antibody Trastuzumab in a Panel of Human Tumor Cell Lines
    Marcoe, K. F.
    Ovechkina, Y.
    Keyser, R.
    Bernards, K.
    Chestnut-Speelman, J.
    Yoshino, K.
    O'Day, C.
    CANCER RESEARCH, 2010, 70
12345